|
Global Health
Partners |
|
The Fastest
Growing Company
in America |
|
|
|
|
|
"Vaccination to
prevent millions
of deaths per
year, and yet
millions more
are dying due to
the lack of
vaccines.
Stringent
regulatory
hurdles and the
perception of
moderate returns
on investment
have not
encouraged
companies like
us to enter the
markets faster."
"Prevention
if better then
cure
—innovation
of new vaccines
and diagnostics
for healthcare
make a real
difference for
the world. To
realize this
goal, we
recognize that
JN resources and
capabilities are
necessary, but
not
sufficient—we
just can’t do it
alone.
Successful,
productive
partnerships are
essential for
JN’s ongoing
pursuit of
innovation and
excellence."
Jeeri R.
Reddy, M.S., Ph.D.
Scientific
Director / CEO
"The
supply of
vaccines, be it
in response to a
pandemic or
seasonal
outbreaks in
Africa, requires
robust
production
processes
supported by
manufacturers
with stringent
supply chain
routines and
quality systems
who are able to
react quickly to
the demand. With
vaccine
candidates,
improved
processes and
increased
capacity,
vaccine
manufacturers
are better
prepared, but
there is still
some way to go
to meet the
goals of JN
operations in
West Africa."
Noel
Koumae. M.D.
Medical
Director and
Chief
Operational
Officer Africa |
|
 |
|
|
|
|
|
|
|
|
The Founder of Corporation |
|
JN-International
Medical Corporation is a
privately held Nebraska
Corporation stated by an
entrepreneur in a rural Nebraska
town in 1998. The founder, while
researching for vaccines during
1995, he founded his own
research by trading rapid
diagnostics in international
market. In a decade's time,
his dreams came to realities and
established a track record of
delivering on the promise of
healthcare products to
international community. Today,
JN is among the world's leading
biotech companies, with
innovated vaccines and
diagnostic products for
detection and prevention of
infectious diseases. JN has
focused its energies and based
its success in 10 straight years
in development of innovative
vaccines and diagnostics, sound
business strategy, and a passion
for people around the world, who
receive our products. JN became
one of the world’s leading
biotechnology companies
practicing world class medicine
with our groundbreaking
scientific discoveries, bringing
to market with Innovative
Vaccines and Diagnostics and
proved the commercial viability
of this new technology through
recognition of our
forward-thinking. |
|
Our Mission |
|
Our mission is to be the leading biotechnology company, using genetic engineering technology to discover, develop, and commercialize diagnostics that address significant medical needs. We commit ourselves to high standards of integrity in contributing to the best interests of international communities, and to seeking significant returns, based on the continual pursuit of scientific and operational excellence.
JN
believes that this goal can be
achieved by means of our product
superiority, affordability and
accessibility. Our organization
has already achieved vaccine
marketing success through a
decade of unique as well as
innovative research and
technology combined with an
innovative marketing strategy. |
|
Company Profile |
|
JN-International
development pipeline has never
been more robust and
promising, with the projects
below under way, JN pipeline
vaccines are composed of
potential vaccines against
Infectious, Sexually transmitted
diseases and Stroke. JN's
clinical trials are crucial to
the exploration of new vaccines
for developing countries that
may address significant unmet
disease prevention. JN's
development pipeline continues
to grow, now numbering over 4
vaccine projects. The pipeline
is also balanced between
breakthrough innovations and new
indications for existing,
well-understood products that
may prevent from common diseases
and disorders.
Company profile with GBC:
TB
Malaria
|
|
What do other people say about our company? |
|
The company’s emphasis on strong basic research combined with an applied focus on unequivocal medical needs has been instrumental to our success and growth. Our company received recognition from the world most popular NGO's, International Health Organizations, and Ministry of Health.
JN/GBC
Contribution on Prevention of
Malaria in Zambia
 |
COUNTY AND REGIONAL OFFICES
|
